| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
group | 0.100 | None | 0.970 | 33 | 0 | 2009 | 2020 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.100 | None | 0.929 | 14 | 0 | 1976 | 2019 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.100 | None | 1.000 | 13 | 0 | 2008 | 2019 | |||||||||
|
PGR antisense RNA 1 | 0.514 | 0.808 |
|
group | 0.090 | None | 0.889 | 9 | 0 | 1996 | 2017 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
group | 0.090 | None | 0.889 | 9 | 0 | 2004 | 2019 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
group | 0.080 | None | 0.875 | 8 | 7 | 2011 | 2019 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
group | 0.080 | None | 0.875 | 8 | 0 | 2004 | 2019 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2009 | 2019 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
group | 0.060 | None | 1.000 | 6 | 1 | 2015 | 2019 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2000 | 2020 | |||||||||
|
Carotid intimal medial thickness | 0.695 | 0.462 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2011 | 2019 | |||||||||
|
microRNA 126 | 0.447 | 0.846 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2016 | 2019 | |||||||||
|
microRNA 210 | 0.460 | 0.846 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2011 | 2019 | |||||||||
|
matrix metallopeptidase 12 | 0.484 | 0.885 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2011 | 2019 | |||||||||
|
microRNA 499a | 0.519 | 0.846 |
|
group | 0.050 | None | 1.000 | 5 | 1 | 2010 | 2018 | |||||||||
|
basic transcription factor 3 pseudogene 11 | 0.519 | 0.731 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2019 | |||||||||
|
facioscapulohumeral muscular dystrophy 1A | 0.638 | 0.808 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2018 | 2019 | |||||||||
|
microRNA 145 | 0.431 | 0.846 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2012 | 2018 | |||||||||
|
microRNA 221 | 0.449 | 0.846 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2015 | 2018 | |||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2018 | |||||||||
|
cystathionine beta-synthase like | 0.540 | 0.808 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2000 | 2010 | |||||||||
|
cystatin 12, pseudogene | 0.641 | 0.615 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2015 | 2019 | |||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
group | 0.030 | None | 0.667 | 3 | 2 | 2003 | 2012 | |||||||||
|
prostate androgen-regulated transcript 1 | 0.483 | 0.885 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2019 | 2019 | |||||||||
|
metastasis associated lung adenocarcinoma transcript 1 | 0.435 | 0.846 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 |